Skip to main content
Clinical Trials/NCT02615522
NCT02615522
Terminated
N/A

Prospektive, Klinische Verlaufsuntersuchung (Post Market Follow-Up) Der primären Knieendoprothese BPK-S Integration

Peter Brehm GmbH1 site in 1 country124 target enrollmentSeptember 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Osteoarthritis, Knee
Sponsor
Peter Brehm GmbH
Enrollment
124
Locations
1
Primary Endpoint
Time until revision
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

Prospective, monocenter post market clinical follow-up of a primary knee replacement bearing the CE-mark.

200 subjects will be recruited and followed up for up to ten years or until revision of the primary knee endoprosthesis, whichever occurs first. Documentation of clinical and radiological parameters within the clinical routine pre-operative and post-operative at 3 and 12 months and 2, 5 and 10 years to evaluate time to revision, pain situation, knee functionality, mobility and stability.

Registry
clinicaltrials.gov
Start Date
September 2016
End Date
November 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Congenital or acquired knee joint defects/deformation or
  • Defects or malfunction of the knee joint or
  • Arthrosis (degenerative, rheumatic) or
  • Post-traumatic arthritis or
  • Symptomatic knee instability or
  • Reconstruction of flexibility or
  • Patients with metal hypersensitivity (ceramic tibia/femur)

Exclusion Criteria

  • Illnesses which can be treated without using a knee joint implant.
  • Acute or chronic infections near the implantation
  • Systemic diseases and metabolic disorders
  • Serious osteoporosis
  • Serious damage to the bone structures that impedes stable implantation of the implant components
  • Diseases that impair bone growth, e.g. cancer, renal dialysis, osteopenia, etc.
  • Bone tumors in the area of the implant anchoring
  • Obesity or overweight of the patient
  • Overload of the knee implant to be expected
  • Abuse of medication, drug abuse, alcoholism or mental disease

Outcomes

Primary Outcomes

Time until revision

Time Frame: 10 years

Secondary Outcomes

  • Improvement of clinical situation based on Knee Society Score(3 and 12 months, 2, 5, 10 years)
  • Documentation of incidents(Up to 10 Years)

Study Sites (1)

Loading locations...

Similar Trials